Amoxapine

This classification denotes a tricyclic antidepressant with the molecular formula C17H16ClN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R63VQ857OT, chemically known as 2-chloro-11-(1-piperazinyl)dibenz(b,f)(1,4)oxazepine but generally known as amoxapine, which bears US NIH Compound Identifier 2170. Amoxapine most often comes in base and acetate forms. European Medicines Agency schedules Amoxapine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05479MIG. The term AMOXAPINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules amoxapine in its Anatomical Therapeutic Chemical (ATC) Classification. AMOXAPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amoxapine under HS 29349990 and SITC 51579. As of Q4 2014, AMOXAPINE remains the US FDA Preferred Term for this commodity. Amoxapine bears US NLM identifiers UMLS ID C0700992 and NCI Concept Code C47397. SMILES: Clc1cc2C(=Nc3c(Oc2cc1)cccc3)N1CCNCC1.